Tandem Diabetes Care (TNDM) Current Leases (2019 - 2026)

Tandem Diabetes Care's Current Leases history runs 8 years deep, the most recent figure standing at $20.1 million for Q1 2026.

• Quarterly Current Leases fell 2.92% year-over-year to $20.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.1 million (down 2.92% YoY) and the FY2025 annual result came in at $19.5 million, up 6.94% from the prior year.
• Current Leases was $20.1 million for Q1 2026 at Tandem Diabetes Care, up from $19.5 million in the prior quarter.
• Across five years, Current Leases topped out at $21.3 million in Q3 2025 and bottomed at $8.1 million in Q1 2022.
• A 5-year average of $16.7 million and a median of $17.8 million in 2023 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2022 — Current Leases slipped 14.46% — and 2023, when it jumped 96.15%.
• Tandem Diabetes Care's Current Leases stood at $13.1 million in 2022, then jumped by 30.02% to $17.1 million in 2023, then increased by 6.73% to $18.2 million in 2024, then advanced by 6.94% to $19.5 million in 2025, then increased by 3.27% to $20.1 million in 2026.
• Business Quant data shows TNDM's Current Leases at $20.1 million in Q1 2026, $19.5 million in Q4 2025, and $21.3 million in Q3 2025.